SYIEY vs. GSK
SYIEY (Symrise Ag PK) and GSK (GlaxoSmithKline plc) are both stocks. SYIEY operates in Specialty Chemicals (Basic Materials), while GSK operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, SYIEY returned 5.62%/yr vs 4.69%/yr for GSK. At a 0.31 correlation, their price movements are largely independent.
Performance
SYIEY vs. GSK - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SYIEY achieves a 24.26% return, which is significantly higher than GSK's 5.12% return. Over the past 10 years, SYIEY has outperformed GSK with an annualized return of 5.62%, while GSK has yielded a comparatively lower 4.69% annualized return.
SYIEY
- 1D
- 0.70%
- 1M
- 6.08%
- YTD
- 24.26%
- 6M
- 24.51%
- 1Y
- -9.31%
- 3Y*
- 0.28%
- 5Y*
- -5.64%
- 10Y*
- 5.62%
GSK
- 1D
- 0.14%
- 1M
- -1.25%
- YTD
- 5.12%
- 6M
- 6.09%
- 1Y
- 38.10%
- 3Y*
- 16.17%
- 5Y*
- 4.56%
- 10Y*
- 4.69%
SYIEY vs. GSK - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SYIEY Symrise Ag PK | 24.26% | -22.96% | -2.97% | 2.69% | -26.32% | 12.44% | 28.00% | 42.13% | -12.46% | 43.81% |
GSK GlaxoSmithKline plc | 5.12% | 51.23% | -5.14% | 9.71% | -33.41% | 26.74% | -17.72% | 29.24% | 13.79% | -2.97% |
Correlation
The correlation between SYIEY and GSK is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.17 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.25 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.28 |
Correlation (All Time) Calculated using the full available price history since Oct 31, 2008 | 0.31 |
The correlation between SYIEY and GSK shifts across timeframes, from 0.17 (1 year) to 0.31 (all time), reflecting how their relationship changes across market environments.
Fundamentals
SYIEY:
$13.75B
GSK:
$103.36B
SYIEY:
€0.66
GSK:
£2.85
SYIEY:
32.60
GSK:
13.47
SYIEY:
1.96
GSK:
2.40
SYIEY:
3.24
GSK:
3.32
SYIEY:
€6.13B
GSK:
£32.78B
SYIEY:
€2.33B
GSK:
£23.87B
SYIEY:
€1.11B
GSK:
£11.30B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SYIEY vs. GSK — Risk / Return Rank
SYIEY
GSK
SYIEY vs. GSK - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Symrise Ag PK (SYIEY) and GlaxoSmithKline plc (GSK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SYIEY | GSK | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.77 | ||
| Sortino ratioReturn per unit of downside risk | -2.38 | ||
| Omega ratioGain probability vs. loss probability | 0.96 | 1.26 | -0.29 |
| Calmar ratioReturn relative to maximum drawdown | -0.30 | 2.05 | -2.36 |
| Martin ratioReturn relative to average drawdown | -0.43 | 5.17 | -5.60 |
Loading charts...
Drawdowns
SYIEY vs. GSK - Drawdown Comparison
The maximum SYIEY drawdown since its inception was -45.61%, smaller than the maximum GSK drawdown of -55.70%. Use the drawdown chart below to compare losses from any high point for SYIEY and GSK.
Loading charts...
Drawdown Indicators
| SYIEY | GSK | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -45.61% | -55.70% | +10.09% |
Max Drawdown (1Y)Largest decline over 1 year | -30.98% | -18.63% | -12.35% |
Max Drawdown (3Y)Largest decline over 3 years | -43.19% | -28.46% | -14.73% |
Max Drawdown (5Y)Largest decline over 5 years | -45.61% | -50.10% | +4.49% |
Max Drawdown (10Y)Largest decline over 10 years | -45.61% | -50.10% | +4.49% |
Current DrawdownCurrent decline from peak | -29.84% | -15.74% | -14.10% |
Average DrawdownAverage peak-to-trough decline | -12.06% | -18.87% | +6.81% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 21.48% | 7.40% | +14.08% |
Volatility
SYIEY vs. GSK - Volatility Comparison
Symrise Ag PK (SYIEY) has a higher volatility of 10.34% compared to GlaxoSmithKline plc (GSK) at 7.15%. This indicates that SYIEY's price experiences larger fluctuations and is considered to be riskier than GSK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SYIEY | GSK | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.34% | 7.15% | +3.19% |
Volatility (6M)Calculated over the trailing 6-month period | 20.23% | 18.73% | +1.50% |
Volatility (1Y)Calculated over the trailing 1-year period | 28.40% | 26.67% | +1.73% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.30% | 25.11% | +0.19% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.36% | 22.89% | +1.47% |
Dividends
SYIEY vs. GSK - Dividend Comparison
SYIEY's dividend yield for the trailing twelve months is around 1.50%, less than GSK's 3.41% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GSK GlaxoSmithKline plc | 3.41% | 3.42% | 4.60% | 3.75% | 5.47% | 4.99% | 5.59% | 4.35% | 5.65% | 5.83% | 6.86% | 5.93% |
SYIEY Symrise Ag PK | 1.50% | 1.63% | 1.11% | 1.04% | 1.02% | 0.77% | 0.52% | 0.63% | 0.95% | 1.89% | 2.49% | 0.83% |
Financials
SYIEY vs. GSK - Financials Comparison
This section allows you to compare key financial metrics between Symrise Ag PK and GlaxoSmithKline plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SYIEY vs. GSK - Profitability Comparison
SYIEY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Symrise Ag PK reported a gross profit of 791.58M and revenue of 2.36B. Therefore, the gross margin over that period was 33.6%.
GSK - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, GlaxoSmithKline plc reported a gross profit of 5.75B and revenue of 7.63B. Therefore, the gross margin over that period was 75.4%.
SYIEY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Symrise Ag PK reported an operating income of 193.99M and revenue of 2.36B, resulting in an operating margin of 8.2%.
GSK - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, GlaxoSmithKline plc reported an operating income of 2.29B and revenue of 7.63B, resulting in an operating margin of 30.1%.
SYIEY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Symrise Ag PK reported a net income of -18.69M and revenue of 2.36B, resulting in a net margin of -0.8%.
GSK - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, GlaxoSmithKline plc reported a net income of 1.74B and revenue of 7.63B, resulting in a net margin of 22.8%.
Frequently Asked Questions
SYIEY and GSK have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SYIEY has higher volatility (10.34%) compared to GSK (7.15%). In terms of maximum drawdown, SYIEY dropped -45.61% vs GSK's -55.70%.
GSK currently has the higher Sharpe Ratio (1.44 vs -0.33), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SYIEY and GSK
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer